How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals (RXRX) has shown volatility recently, with a 3.13% decline on July 8, 2026, amidst broader market movements. The company is preparing for an earnings report, expected to show ...